Literature DB >> 10905539

Anti- and pro-oxidative properties of PADMA 28, a Tibetan herbal formulation.

M Suter1, C Richter.   

Abstract

There is growing public interest in traditional medicine. PADMA 28, a multicompound herbal preparation derived from Tibetan medicine, has proven efficacy in some clinical trials and tests at the cellular level. We report here on studies of PADMA 28 at the molecular level. Extracts of PADMA 28 contain both reducing and metal ion-chelating substances. In this way, PADMA 28 acts as a powerful antioxidant or prooxidant, depending on its concentration and the reaction under study.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10905539     DOI： 10.1179/rer.2000.5.1.17

Source DB:  PubMed          Journal:  Redox Rep        ISSN： 1351-0002            Impact factor:   4.412


  6 in total

1.  Synthesis of α - mangostin-D-glucoside in supercritical carbon dioxide media.

Authors:  A S Zarena; Kadimi Udaya Sankar
Journal:  J Food Sci Technol       Date:  2015-02-27       Impact factor: 2.701

2.  Antioxidant, Cytotoxic, and Antibacterial Activities of the Selected Tibetan Formulations Used in Gandaki Province, Nepal.

Authors:  Madan Dhakal; Prakash Poudel; Upma Jha; Suresh Jaiswal; Khem Raj Joshi
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-27       Impact factor: 2.629

3.  Amelioration of hepatic fibrosis via Padma Hepaten is associated with altered natural killer T lymphocytes.

Authors:  I Ginsburg; E Koren; A Horani; M Mahamid; S Doron; N Muhanna; J Amer; R Safadi
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

4.  Apoptosis induced by the Tibetan herbal remedy PADMA 28 in the T cell-derived lymphocytic leukaemia cell line CEM-C7H2.

Authors:  Marcel Jenny; Wolfgang Schwaiger; David Bernhard; Oliver A Wrulich; Daria Cosaceanu; Dietmar Fuchs; Florian Ueberall
Journal:  J Carcinog       Date:  2005-09-02

5.  Pathway-focused bioassays and transcriptome analysis contribute to a better activity monitoring of complex herbal remedies.

Authors:  Angela Klein; Oliver A Wrulich; Marcel Jenny; Peter Gruber; Kathrin Becker; Dietmar Fuchs; Johanna M Gostner; Florian Uberall
Journal:  BMC Genomics       Date:  2013-02-27       Impact factor: 3.969

6.  The Tibetan herbal medicines Padma 28 and Padma Circosan inhibit the formation of advanced glycation endproducts (AGE) and advanced oxidation protein products (AOPP) in vitro.

Authors:  Ewa Grzebyk; Agnieszka Piwowar
Journal:  BMC Complement Altern Med       Date:  2014-08-05       Impact factor: 3.659
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.